CX3CL1 and asthma: A previous study exposed that the administration of a CX3CL1 antagonist to antigen-sensitive mice promoted the survival of Th2 cells in the inflamed airway and suppressed airway inflammation.[21] Our current results demonstrate that CXC3L1 expression is correlated with infiltration of multiple immune cell types in asthma.